BR9802163A - Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins) - Google Patents

Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins)

Info

Publication number
BR9802163A
BR9802163A BR9802163A BR9802163A BR9802163A BR 9802163 A BR9802163 A BR 9802163A BR 9802163 A BR9802163 A BR 9802163A BR 9802163 A BR9802163 A BR 9802163A BR 9802163 A BR9802163 A BR 9802163A
Authority
BR
Brazil
Prior art keywords
neoflavonoid
substances
treatment
pharmaceutical compositions
viral infections
Prior art date
Application number
BR9802163A
Other languages
Portuguese (pt)
Inventor
Marcal De Queiroz Paulo
Original Assignee
Ind E Com De Prod Farmaceutico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind E Com De Prod Farmaceutico filed Critical Ind E Com De Prod Farmaceutico
Priority to BR9802163A priority Critical patent/BR9802163A/en
Publication of BR9802163A publication Critical patent/BR9802163A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<B>COMPOSIçõES FARMACêUTICAS PARA O TRATAMENTO DE INFECçõES VIRAIS COMPREENDENDO SUBSTâNCIAS NEOFLAVONOIDES (4-ARILCULMARINAS)<D> A presente invenção diz respeito ao uso de substâncias neoflavonoides para a preparação de composições farmacêuticas adequadas em particular à aplicação tópica para a profilaxia e o tratamento de infecções provocadas pelo vírus do DNA, particularmente dos herpesvírus, ou seja, Herpes simplex (labial ou genital) e Herpes zoster.<B> PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS UNDERSTANDING NEOFLAVONOID SUBSTANCES (4-ARYCULMARINS) <D> The present invention relates to the use of neoflavonoid substances for the preparation of pharmaceutical compositions suitable in particular for topical application for the treatment and prophylaxis infections caused by the DNA virus, particularly herpesviruses, that is, Herpes simplex (labial or genital) and Herpes zoster.

BR9802163A 1998-05-29 1998-05-29 Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins) BR9802163A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR9802163A BR9802163A (en) 1998-05-29 1998-05-29 Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR9802163A BR9802163A (en) 1998-05-29 1998-05-29 Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins)

Publications (1)

Publication Number Publication Date
BR9802163A true BR9802163A (en) 2000-11-28

Family

ID=4069837

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9802163A BR9802163A (en) 1998-05-29 1998-05-29 Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins)

Country Status (1)

Country Link
BR (1) BR9802163A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858602B2 (en) 2001-06-12 2005-02-22 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858602B2 (en) 2001-06-12 2005-02-22 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US6916848B2 (en) 2001-06-12 2005-07-12 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US6924314B2 (en) 2001-06-12 2005-08-02 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US6946491B2 (en) 2001-06-12 2005-09-20 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7012071B2 (en) 2001-06-12 2006-03-14 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7041659B2 (en) 2001-06-12 2006-05-09 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7045541B2 (en) 2001-06-12 2006-05-16 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7101910B2 (en) 2001-06-12 2006-09-05 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7329782B2 (en) 2001-06-12 2008-02-12 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7547802B2 (en) 2001-06-12 2009-06-16 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US7863475B2 (en) 2001-06-12 2011-01-04 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
US8487000B2 (en) 2001-06-12 2013-07-16 Wellstat Therapertics Corporation Compound for the treatment of metabolic disorders
US8552062B2 (en) 2001-06-12 2013-10-08 Wellstat Therapeutics Corporation Methods for the treatment of metabolic disorders such as diabetes
US8604083B2 (en) 2001-06-12 2013-12-10 Wellstat Therapeutics Corporation Method for the treatment of metabolic disorders

Similar Documents

Publication Publication Date Title
BR9810745A (en) Benzimidazole derivatives
BR9811121A (en) Product, pharmaceutical composition, and use of a product
BR0211863A (en) 1-alkyl or 1-cycloalkyltriazolo [4,3a] quinazolin-5-ones as phosphodiesterase inhibitors
BR9911488A (en) Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound
BR0316407A (en) Antiviral nucleoside derivatives
PT80079B (en) PROCESS FOR THE PREPARATION OF ANTI-VIRUS PHARMACEUTICAL COMPOSITIONS CONTAINING 2-DIETILAMINO-2 &#39;, 6&#39;-ACETOXYLID (LIDOCAINE)
HUP0102441A2 (en) Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
UY26724A1 (en) METHODS AND COMPOSITIONS FOR TREATING HEPATITIS C VIRUSES
BR112022026321A2 (en) 1&#39;-CYAN NUCLEOSIDE ANALOGS AND USES THEREOF
BR0013281A (en) Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation and use as antitumor agents
BR9806870A (en) Compound, process for the prophylaxis or treatment of a clinical condition in a mammal, pharmaceutical formulation, and use of a compound and process to prepare it.
BR9908015A (en) Compositions comprising viruses and methods for concentrating virus preparations
YU7296A (en) Novel pharmaceutical combination containing antivirus substance and one anti-inflamatory glucocorticoid
BRPI0411900B8 (en) compounds and pharmaceutical compositions comprising them
DK169991D0 (en) ANTIVIRAL RELATIONS
WO2000012534A3 (en) A method of inhibiting formation of infectious herpes virus particles
BR9406509A (en) Compounds for their preparation, use of the same pharmaceutical compositions and for prophylaxis and for the therapeutic treatment of malaria and diseases caused by leishmania toxoplasma gondil pneumocy
BRPI0413430A (en) amide derivatives
DK449988D0 (en) PHARMACEUTICAL PREPARATION WITH Double-stranded RNA
BR9802163A (en) Pharmaceutical compositions for the treatment of viral infections comprising neoflavonoid substances (4-arylcoumarins)
BR9916043A (en) Compound, use of the same and its pharmaceutically acceptable salts, and pharmaceutical composition for the treatment of viral herpes infections in patients
BR9706938A (en) Compound use of the same pharmaceutical formulation and processes to produce the compound and for the treatment or prevention of symptoms or effects of a viral infection in an infected mammal including a human
NO983090L (en) Therapeutic compounds
BR9707400A (en) Vaccines against gene 63 product of varicella zoster virus.
WO2002013764A3 (en) Methods for treating subjects infected with a herpes virus or neisseria gonorrheae

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law